Amrutanjan Health Care logo

Amrutanjan Health Care financials and balance sheet

NSE: AMRUTANJANBSE: 590006Pharmaceuticals & BiotechnologySmall Cap

Last close ₹487.65down ₹9.35 (1.88%)BSE ₹487.65

Share price at the NSE close on 23 Oct 2026. Previous close ₹497.00.

52-week range of traded prices to 23 Oct 2026
₹476.50Low, 16 Sep 2026₹760.15High, 29 Oct 2025
Market cap
₹1,410 Cr1,245th largest listed
P/E
26.1
P/E without one-offs
21.7
P/B
3.8
Dividend yield
1.00%
ROE
15.5%
ROE without one-offs
18.6%
ROCE
18.0%
Debt to equity
0.00
Volume, NSE
35,01263.2% delivered

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Amrutanjan Health Care annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹503 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 0.9% of operating profit in the first full year.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue503
  2. Materials and goods−244
  3. Employee costs−64
  4. Other expenses−119
  5. Operating profit76
  6. Depreciation−6.3
  7. Other income+18
  8. One-off items−8.9
  9. Finance costs−0.2
  10. Profit before tax78
  11. Tax−20
  12. Net profit58

What the company owns

  • Plant, investments and other assets₹374 Cr
  • Receivables₹61 Cr
  • Inventory₹37 Cr
  • Cash and bank₹33 Cr
  • Current investments₹3 Cr

What pays for it: net worth and liabilities

  • Net worth₹370 Cr
  • Owed to suppliers₹71 Cr
  • Other liabilities₹68 Cr

Amrutanjan Health Care business segments, year to Mar 2026

A reportable segment is a line of business the company must report on its own. Standalone, ₹ crore, as the company reports them. A segment at a loss has no share of profit.Amrutanjan Health Care segment results by quarter

Revenue by segment

₹503 CrTotal
  • OTC Products₹328 Cr65.3% of total
  • Women's Hygiene & Personal Care₹140 Cr27.8% of total
  • Beverages₹32 Cr6.3% of total
  • Others₹3 Cr0.6% of total

Profit by segment

  • OTC Products₹83.4 Cr100.0% of total

Segment results by year

Standalone, ₹ crore, years to March.

  • OTC Products

    Revenue, ₹ crore
    Profit, ₹ crore
  • Women's Hygiene & Personal Care

    Revenue, ₹ crore
    Profit, ₹ crore
  • Beverages

    Revenue, ₹ crore
    Profit, ₹ crore
  • Others

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue of all businesses253261333406380421452503
Company revenue, as in its results253261333406380421452503
Revenue231241314372345380290328
Revenue growth–4.3%30.5%18.4%−7.3%10.2%−23.8%13.2%
Profit3632788349516683
Profit growth–−12.9%145.8%6.1%−41.1%4.4%28.7%27.3%
Margin15.8%13.2%24.8%22.3%14.1%13.4%22.6%25.4%
Return on capital100.1%94.7%1,053.9%230.2%130.6%160.8%520.0%384.3%
Assets6768519190906879
Liabilities3035445553595557
Capital employed363473637321322
Revenue––––––124140
Revenue2118173232403632
Revenue22122113
Profit is before tax and finance costs, the way companies report their segments.

Profit and loss

Standalone, ₹ crore, years to March.Amrutanjan Health Care quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 28 MayMar 2020Filed 18 JunMar 2021Filed 28 MayMar 2022Filed 3 JunMar 2023Filed 31 MayMar 2024Filed 13 JunMar 2025Filed 23 JunMar 2026Filed 8 May
Revenue from operations220225253261333406380421452503
190196222231258326335370394427
Materials and goods bought8697119117140180182212223244
Employee costs––3339424849485964
Other expenses––70747698104110111119
Operating profit before depreciation29283131757944515876
Operating margin13.4%12.6%12.4%11.7%22.5%19.6%11.7%12.2%12.9%15.1%
Materials, % of revenue––46.9%44.8%42.1%44.5%47.9%50.3%49.4%48.6%
Employee costs, % of revenue––13.2%15.1%12.7%11.9%12.9%11.5%13.1%12.7%
Other expenses, % of revenue––27.5%28.4%22.7%24.1%27.5%26.1%24.6%23.6%
Depreciation and amortisation2334445676
Operating profit after depreciation27252826717639455269
Other income5678111515171818
Finance costs0000100000
Profit before one-off items and tax32313534829154626987
One-off items320000000−9
Profit before tax35333534829154626978
1213109212314171820
Profit from discontinued businesses––0–––––––
Net profit23202525616740455158
Other comprehensive income––−100−1−10−10
Total comprehensive income––2425616739455058
Net margin10.4%8.9%9.7%9.6%18.4%16.6%10.5%10.7%11.3%11.5%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2017 and Mar 2018 they do not, so they are left blank.
Earlier years, Mar 2008 to Mar 2016
₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Revenue from operations759190103115135139163184
6377779096116116139153
Materials and goods bought23404245436065
Operating profit before depreciation121313131919232532
Operating margin15.8%14.7%14.0%12.9%16.5%14.2%16.7%15.2%17.2%
Depreciation and amortisation111233323
Operating profit after depreciation101211121616202229
Other income076544356
Finance costs100022200
Profit before one-off items and tax–1917161818212735
One-off items––2––––––
Profit before tax101919161818212735
Tax4775567912
Net profit59312111312151722
Net margin6.7%102.4%13.2%10.3%11.1%9.0%10.5%10.6%12.2%
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 28 MayMar 2020Filed 18 JunMar 2021Filed 28 MayMar 2022Filed 3 JunMar 2023Filed 31 MayMar 2024Filed 13 JunMar 2025Filed 23 JunMar 2026Filed 8 May
146159216265291288327370
Share capital33333333
Reserves143157213262288286324367
Borrowings00000000
36395277637085126
6777881012
Total assets188205274350362367421509
4880517510371131217
140126223275260296291292
Net debt−83−36−145−95−75−27−83−36
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 28 MayMar 2022Filed 3 JunMar 2023Filed 31 MayMar 2024Filed 13 JunMar 2025Filed 23 JunMar 2026Filed 8 May
16.953.219.227.950.936.0
16.977.435.344.468.855.0
−60.4−6.5−12.5−9.17.8−12.4
Receivables7.3−20.64.8−17.0−8.2−5.7
Inventories6.3−8.5−2.8−0.11.6−10.1
Payables9.523.7−10.79.514.62.9
Other working capital−83.4−1.0−3.8−1.6−0.20.5
Tax paid0.0−24.2−16.1−16.5−17.9−19.0
Capital spending2.023.58.96.735.655.0
Free cash flow15.029.710.321.215.3−19.0
−14.9−36.2−2.519.2−31.0−21.2
−6.3−17.7−14.0−48.3−13.5−13.6
Dividends paid4.713.413.413.413.313.2
Shares bought back1.00.00.0–0.00.0
Shares issued0.00.00.00.00.00.0
Net change in cash−4.3−0.72.7−1.26.41.1
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020. Shares bought back is left blank for the year to Mar 2024: the cash-flow statement states no buyback, while the company bought back shares in a tender offer that closed in the period, so the line is not given.

Per share

Standalone, ₹ per share, years to March.Amrutanjan Health Care dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 28 MayMar 2020Filed 18 JunMar 2021Filed 28 MayMar 2022Filed 3 JunMar 2023Filed 31 MayMar 2024Filed 13 JunMar 2025Filed 23 JunMar 2026Filed 8 May
₹7.82₹13.67₹8.38₹8.58₹20.94₹23.05₹13.65₹15.56₹17.58₹20.03
As stated that year₹15.63₹13.67₹8.38₹8.58₹20.94₹23.05₹13.65₹15.56₹17.58₹20.03
₹7.82₹13.67₹8.38₹8.58₹20.93₹23.03₹13.63₹15.56₹17.58₹20.03
₹1.93₹1.95₹2.15₹2.10₹4.20₹4.60₹4.60₹4.60₹4.60₹4.90
Book value per share––₹49.86₹54.54₹73.75₹90.70₹99.47₹99.79₹112.97₹128.06
Dividend payout24.6%28.5%25.6%24.5%20.1%20.0%33.8%29.6%26.2%24.5%
Shareholder yield––––0.3%0.6%0.8%–0.7%0.9%
Market cap at the year end (₹ crore)8647909049641,6592,3231,6841,7941,8851,427
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from. The dividend as declared is blank for the year to Mar 2018: its payments were declared on different share counts, a split or bonus between them, so they do not add to one figure. Shareholder yield is left blank for the year to Mar 2024: the cash-flow statement states no buyback, while the company bought back shares in a tender offer that closed in the period, so the line is not given.
RatioMar 2017Mar 2018Mar 2019Filed 28 MayMar 2020Filed 18 JunMar 2021Filed 28 MayMar 2022Filed 3 JunMar 2023Filed 31 MayMar 2024Filed 13 JunMar 2025Filed 23 JunMar 2026Filed 8 May
Revenue growth19.1%2.4%12.7%3.3%27.3%21.9%−6.5%11.0%7.3%11.2%
Operating profit growth−7.1%−3.6%10.2%−1.8%143.4%6.3%−44.1%15.4%13.6%30.0%
Net profit growth1.9%−12.6%22.7%2.3%143.9%9.8%−40.7%12.9%13.0%13.9%
Earnings per share growth–74.9%−38.7%2.4%144.1%10.1%−40.8%14.0%13.0%13.9%
––16.8%16.4%32.6%28.0%14.3%15.5%16.5%16.6%
–––−0.4 pts16.2 pts−4.7 pts−13.6 pts1.2 pts1.0 pts0.1 pts
From the net margin–––−0.2 pts15.1 pts−3.2 pts−10.2 pts0.3 pts0.8 pts0.4 pts
From asset turnover–––−0.2 pts1.4 pts−1.9 pts−3.2 pts1.2 pts−0.1 pts−1.0 pts
From borrowing–––0.0 pts−0.2 pts0.4 pts−0.2 pts−0.3 pts0.3 pts0.7 pts
Return on capital employed––19.3%16.5%33.0%28.5%13.5%15.7%15.8%18.7%
Cash conversion––––27.7%79.1%48.2%62.1%100.1%62.1%
Interest cover221.3201.0342.1119.2142.2156.2508.2288.2235.7355.7
Debt to equity––0.000.000.000.000.000.000.000.00
Receivable days––4737193432414544
Inventory days––4574455358504556
Payable days––92981061229596113106
Cash conversion cycle, days––013−41−35−6−5−23−6
Working capital days––307028921161739994
Asset turnover––1.351.331.391.301.071.161.151.08
Assets per rupee of net worth––1.291.291.281.301.281.261.281.34
Sales per rupee of plant––10.0210.2214.5314.928.188.929.4710.09
Capital spending to depreciation––––0.536.181.711.115.458.70
Plant being built, % of plant in use––––1.8%59.8%2.4%5.0%33.9%211.8%
No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
12.5%
Cash from operations against operating profit
47.5%
Measure10 years5 years3 years
Revenue growth, yearly rate10.5%8.6%9.8%
Profit growth, yearly rate10.0%−1.1%13.3%
Return on equity, average–18.2%16.2%
Return on capital employed, average–18.4%16.7%
Operating margin, average14.4%14.3%13.4%
Net margin, average11.7%12.1%11.2%
Asset turnover, average–1.151.13
Cash conversion cycle, days, average–−15−11
Interest cover, average257.0308.8293.2
Debt to equity, average–0.000.00

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations18711536
Cash from investing−72−33−21
Cash from financing−107−75−14
Capital spending1309755
Dividends paid674013
Shares bought back––0
Shares issued for cash000
Borrowings raised000
Borrowings repaid000

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9–––734674
Altman Z-scorePublished threshold 1.81–16.6516.0121.0020.1917.4717.2715.219.07
Beneish M-scorePublished threshold −1.78–––−2.17−0.99−2.12−2.12−1.56−2.00
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–––24.6816.106.49−0.587.849.28
Cash from operations to profit, 3 yearsPublished threshold 0.7 times–––––0.530.660.720.75
Receivables growth less revenue growthOur threshold 0 percentage points––−22.90−60.5594.66−7.2334.079.30−2.59
Inventory growth less cost-of-goods growthOur threshold 0 percentage points––64.21−46.1320.2010.02−16.13−11.0627.54
Other current assets growth less revenue growthOur threshold 5 per cent of revenue––11.561.0017.861.8716.63−15.026.53
Assets under construction, years of additionsOur threshold 2 years of additions–––0.412.010.050.342.3012.56
Effective tax ratePublished threshold 17.16 per cent39.1628.9227.2025.2925.8225.7427.4026.4725.64
Tax charged less tax paid, % of profitOur threshold 10 percentage points––––−0.89−4.200.770.551.21
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
31 Jul 2026CARE Ratings Limited (opens in a new tab)Issuer RatingCARE ANew, NewStable
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.